Xenon Pharmaceuticals Inc. - Common Shares (XENE)
CUSIP: 98420N105
Q2 2015 13F Holders as of 30 Jun 2015
- Type / Class
- Equity / Common Shares
- Shares outstanding
- 92,799,600
- Total 13F shares
- 4,806,596
- Share change
- +356,752
- Total reported value
- $55,420,000
- Price per share
- $11.53
- Number of holders
- 25
- Value change
- +$3,173,766
- Number of buys
- 17
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP 98420N105?
CUSIP 98420N105 identifies XENE - Xenon Pharmaceuticals Inc. - Common Shares in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 98420N105:
Top shareholders of XENE - Xenon Pharmaceuticals Inc. - Common Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
1.4%
|
1,256,239
|
$21,184,000 | — | 31 Mar 2015 | |
| Capital World Investors |
13F
|
Company |
0.71%
|
659,497
|
$11,122,000 | — | 31 Mar 2015 | |
| Visium Asset Management, LP |
13F
|
Company |
0.51%
|
475,000
|
$8,011,000 | — | 31 Mar 2015 | |
| Invesco Private Capital, Inc. |
13F
|
Company |
0.48%
|
444,655
|
$7,626,000 | — | 31 Mar 2015 | |
| BVF INC/IL |
13F
|
Company |
0.42%
|
391,424
|
$6,601,000 | — | 31 Mar 2015 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.36%
|
330,202
|
$5,569,000 | — | 31 Mar 2015 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.24%
|
225,000
|
$3,795,000 | — | 31 Mar 2015 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.24%
|
220,570
|
$3,720,000 | — | 31 Mar 2015 | |
| Ativo Capital Management LLC |
13F
|
Company |
0.15%
|
137,389
|
$2,317,000 | — | 31 Mar 2015 | |
| Novo Holdings A/S |
13F
|
Company |
0.14%
|
127,563
|
$2,151,000 | — | 31 Mar 2015 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.12%
|
110,000
|
$1,855,000 | — | 31 Mar 2015 | |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC |
13F
|
Individual |
0.02%
|
22,479
|
$379,000 | — | 31 Mar 2015 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.01%
|
12,300
|
$207,000 | — | 31 Mar 2015 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.01%
|
11,999
|
$202,000 | — | 31 Mar 2015 | |
| Spark Investment Management LLC |
13F
|
Company |
0.01%
|
11,296
|
$188,000 | — | 31 Mar 2015 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0%
|
3,889
|
$65,000 | — | 31 Mar 2015 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
3,033
|
$51,000 | — | 31 Mar 2015 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
2,464
|
$42,000 | — | 31 Mar 2015 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0%
|
2,089
|
$35,000 | — | 31 Mar 2015 | |
| Winslow, Evans & Crocker, Inc. |
13F
|
Company |
0%
|
1,086
|
$18,316 | — | 31 Mar 2015 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
1,000
|
$17,000 | — | 31 Mar 2015 | |
| UBS Group AG |
13F
|
Company |
0%
|
346
|
$6,000 | — | 31 Mar 2015 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
324
|
$5,000 | — | 31 Mar 2015 |
Institutional Holders of Xenon Pharmaceuticals Inc. - Common Shares (XENE) as of Q2 2015
As of 30 Jun 2015,
Xenon Pharmaceuticals Inc. - Common Shares (XENE) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,806,596 shares.
The largest 10 holders included
FMR LLC, BVF INC/IL, Capital World Investors, ROYAL BANK OF CANADA, Visium Asset Management, LP, Invesco Private Capital, Inc., Point72 Asset Management, L.P., PERCEPTIVE ADVISORS LLC, Novo A/S, and EcoR1 Capital, LLC.
This page lists
25
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2015 vs Q1 2015 Across Filers
Q1 2015 holders
23
Q2 2015 holders
25
Holder diff
2
| Investor | Q1 2015 Shares | Q2 2015 Shares | Share Diff | Share Chg % | Q1 2015 Value $ | Q2 2015 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.